Sofia® SARS Antigen FIA by Quidel

rapid antigen testing

The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 analyzer, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.

Advanced result technology

Sofia 2 Fluorescent Immunoassay Analyzer

The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 analyzer, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.

Key Benefits

asymptomatic testing

The first antigen test approved for asymptomatic populations in Canada

dual work modes

Adjusts to your volume fluctuations, allows for high throughput and batch sampling in READ NOW Mode

rapid results

Results in 15 minutes to support dispositioning of patients

everything included

Ready for use with the Sofia 2 nasal swab procedure

self-contained test cassette

Clean, easy to use and dispose of

objective & Automated

Eliminates the subjectivity of a visual read

resources

Time to results                      15 minutes


Sample type                           Direct nasal swab


Kit storage conditions          Room temperature (15ºC to 35ºC / 59ºF to 86ºF)


Controls                                  Positive and negative, included in kit


PPA                                          96.7%*


NPA                                         100%


Shelf-life                                 24 months from date of manufacture


* For patients within the first 5 days of the onset of symptoms

Resources